A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition — Stella
A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(71 sites)
United States
Arizona Liver Health, Chandler, Arizona
The Institute for Liver Health II LLC DBA Arizona Clinical Trials - Flagstaff, Flagstaff, Arizona
The Institute for Liver Health II LLC DBA Arizona Liver Health - Peoria, Peoria, Arizona
Adobe Clinical Research, Tucson, Arizona
Arizona Liver Health - Tucson, Tucson, Arizona
Del Sol Research Management, LLC, Tucson, Arizona
San Fernando Valley Health Institute, Canoga Park, California
Velocity Clinical Research, Chula Vista, California
Southern California Research Center, Coronado, California
Ark Clinical Research - Fountain Valley, Fountain Valley, California
Velocity Clinical Research, Gardena, California
Velocity Clinical Research - Huntington Park, Huntington Park, California
Om Research Llc, Lancaster, California
Ark Clinical Research - Long Beach, Long Beach, California
Velocity Clinical Research - Westlake, Los Angeles, California
Clinnova Research Solutions, Orange, California
Knowledge Research Center, St. Joseph's Medical Tower, Orange, California
National Research Institute, Panorama City, California
California Liver Research Institute, Pasadena, California
Cadena Care Inst., Poway, California
Inland Empire Liver Foundation, Rialto, California
Precision Research Institute - San Diego, San Diego, California
University of Colorado Anschutz Medical Campus, Aurora, Colorado